AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Clinical trial NCT07403721 · RECRUITING

Trial details

NCT number: NCT07403721
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)

Start date: 2026-04-08
Primary completion: 2028-07-28
Enrollment: 464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.